OJOG  Vol.5 No.5 , May 2015
Vulvar Dermatoses: Effect of a Synergistic Treatment with a Moisturizing and Healing Product on the Course of the Disease
ABSTRACT

Background: Vulvar dermatoses are inflammatory disorders of genital skin causing itch, burning, and plaques with overlying excoriation and linear fissures. Objective: To assess the effectiveness of a soft foam based on Tiab® system (TF), complex of titanium micro crystals covalently bound with silver ions associated with hyaluronic acid, in the supportive treatment of lichen sclerosus (LS) and lichen simplex chronicus (LSC), the two common vulvar dermatoses. Method: 20 patients with the diagnosis of LS or LSC received an 4-week treatment, during which the subjects applied Mometasone furoate in the form 0.1% cream were treated with Mometasone furoate 0.1% cream in combination with TF once a day. Clinical symptoms (itching and burning) and signs (vulvar suface disruption) were documented at baseline and at the end of the four-week treatment. Results: There was a significant reduction of symptoms between the basal scores and the symptoms complaints at 4-week treatment. Moreover, a significant reduction of excoriations and linear fissures was observed. Conclusion: The present study shows that daily application of TF can be an effective adjunct for the treatment of vulvar dermatosis. The foam had not only a moisturizer action, it may also be associated with a reduction in epithelial disruption in the form of excoriations and fissures.


Cite this paper
Murina, F. and Vicariotto, F. (2015) Vulvar Dermatoses: Effect of a Synergistic Treatment with a Moisturizing and Healing Product on the Course of the Disease. Open Journal of Obstetrics and Gynecology, 5, 239-243. doi: 10.4236/ojog.2015.55035.
References
[1]   Moyal-Barracco, M. and Wendling, J. (2014) Vulvar Dermatosis. Clinical Obstetrics & Gynaecology, 28, 946-958.
http://dx.doi.org/10.1016/j.bpobgyn.2014.07.005

[2]   Oyama, N., Chan, I., Neill, S.M., et al. (2003) Autoantibodies to Extracellular Matrix Protein 1 in Lichen Sclerosus. Lancet, 362, 118Y23.

[3]   Lynch, P.J. (2004) Lichen Simplex Chronicus (Atopic/Neurodermatitis) of the Anogenital Region. Dermatology and Therapy, 17, 8-19.

[4]   Edwards, S., Bates, C., Lewis, F., Sethi, G. and Grover, D. (2014) 2014 UK National Guideline on the Management of Vulval Conditions. International Journal of STD & AIDS.
http://dx.doi.org/10.1177/0956462414554271

[5]   Simonart, T., Lahaye, M. and Simonart, J.M. (2008) Vulvar Lichen Sclerosus: Effect of Maintenance Treatment with a Moisurizer on the Course of the Disease. Menopause, 15, 74Y7.

[6]   Neill, SM., Lewis, F.M., Tatnall, F.M. and Cox, N.H., British Association of Dermatologists (2010) British Association of Dermatologists’ Guidelines for the Management of Lichen Sclerosus 2010. British Journal of Dermatology, 163, 672Y82.

[7]   Virgili, A., Corazza, M., Minghetti, S. and Borghi, A. (2015) Growing Evidence for Topical Mometasone Fuoroate in the Treatment of Vulvar Lichen Sclerosus. Maturitas, 80, 113-115.
http://dx.doi.org/10.1016/j.maturitas.2014.09.005

[8]   Murina, F., Rehman, S., Di Francesco, S., Mantegazza, V., Felice, R. and Bianco, V. (2015) Vulvar Lichen Sclerosus: A Comparison of the Short-Term Topical Application of Clobetasol Dipropionate 0.05% versus Mometasone Furoate 0.1. Journal of Lower Genital Tract Disease, 19, 149-151.
http://dx.doi.org/10.1097/LGT.0000000000000065

[9]   Huang, X., Tanojo, H., Lenn, J., Deng, H. and Krochmal, L. (2005) A Novel Foam Vehicle for Delivery of Topical Corticosteroids. Journal of the American Academy of Dermatology, 53, S26-S38.
http://dx.doi.org/10.1016/j.jaad.2005.04.028

 
 
Top